Correction: Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer

Albeituni, S. H., C. Ding, M. Liu, X. Hu, F. Luo, G. Kloecker, M. Bousamra, II, H.-g. Zhang, and J. Yan. 2016. Yeast-derived particulate β-glucan treatment subverts the suppression of myeloid-derived suppressor cells (MDSC) by inducing polymorphonuclear MDSC apoptosis and monocytic MDSC differentiation to APC in cancer. J. Immunol. 196: 2167–2180.

A source of funding was omitted in this article. The corrected funding information footnote should read “This work was supported by National Institutes of Health Grants R01CA150947 and P01CA163223 (to J.Y.), by a grant from the Kentucky Lung Cancer Research Program, and by American Cancer Society Grant RSG-14-199-01 (to C.D.). H.-g.Z. is supported by a Research Career Scientist Award.”